Physician

Anna Lucy Sobol, M.D.

According to 2025 Medicare claims, Anna Sobol, M.D. (NPI: 1386627677) practices medical oncology, with the plurality of this provider's patient population coming from Wilkes, NC. This provider's primary affiliated billing organization is WAKE FOREST UNIVERSITY HEALTH SCIENCES (NPI: 1003803032; TIN: 223849199) and primary practice location at 28659-3506. Sobol is affiliated with the CHESS Genesis, LLC (ACO ID: D0237), participating under the REACH model.

Sobol's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 352 traditional Medicare patients, billed 1,385 HCPCS/CPT codes, and received $85,000 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 843 prescription claims across 190 beneficiaries totaling $1,114,864 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 11 claims. Open Payments data shows 9 records totaling $185. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $1,548,918 to $1,114,864. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $18,218 to $7,296.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	412	1,210	$63,224
2016	398	1,200	$71,927
2017	470	1,191	$70,734
2018	448	1,252	$78,530
2019	431	1,282	$93,999
2020	337	977	$71,206
2021	268	981	$94,298
2022	335	935	$84,224
2023	308	781	$63,931
2024	352	1,385	$85,000

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	279	2,608	$1,548,918
2016	258	2,347	$2,450,690
2017	261	1,821	$3,417,565
2018	244	1,436	$3,939,062
2019	251	1,525	$5,038,055
2020	182	1,124	$4,740,863
2021	171	1,030	$4,752,495
2022	170	781	$3,352,869
2023	149	638	$1,511,256
2024	190	843	$1,114,864

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	14	164	$16,430
2016	24	187	$12,899
2017	N/R	122	$5,602
2018	N/R	41	$1,956
2019	13	103	$8,397
2020	16	59	$5,132
2021	13	117	$8,516
2022	N/R	73	$4,869
2023	N/R	100	$15,523
2024	N/R	11	$479

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	83	83	$130
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	183	419	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	166	241	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	62	67	$48
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	196	447	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	18	516	$201,371
Eliquis	Apixaban	27	1,320	$24,893
Exemestane	Exemestane	13	870	$3,655
Anastrozole	Anastrozole	140	8,700	$1,929
Tamoxifen Citrate	Tamoxifen Citrate	79	4,960	$1,472

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	11	$479

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$185	Celgene Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

Medical oncology providers
Providers within practice ZIP code 28659-3506
Providers whose plurality patient county is Wilkes, NC
Providers in North Carolina whose primary affiliated billing organization is WAKE FOREST UNIVERSITY HEALTH SCIENCES
Providers in North Carolina affiliated with CHESS Genesis, LLC (REACH)

FAQ

What Medicare data is available for Anna Lucy Sobol, M.D.?

Tedicare shows public-source Medicare data for Anna Lucy Sobol, M.D. (NPI 1386627677), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anna Lucy Sobol, M.D. have ACO affiliation data?

Anna Lucy Sobol, M.D. is shown with ACO affiliation data for CHESS Genesis, LLC (REACH, ACO ID D0237).

What billing organization is linked to Anna Lucy Sobol, M.D.?

Anna Lucy Sobol, M.D. is linked to WAKE FOREST UNIVERSITY HEALTH SCIENCES (billing NPI 1003803032) in the available physician profile data.

Does Anna Lucy Sobol, M.D. have Open Payments data?

Anna Lucy Sobol, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.